• 한국임상수의학회지
• /
• 제17권1호
• /
• pp.275-278
• /
• 2000

A 3-year-old yorkshire terrier was examined because of the green-like vaginal discharge. Abdominal ultrasonographs revealed dead fetuses in the abdominal cavity. Surgical exploration revealed fetuses located in the region of the uterine wall, the omentum, the ileum, and the upper right side of the liver respectively. Fetal structures were removed and an ovariohysterectomy was performed. The abdominal cavity was flushed with warm saline and then the incision closed. These fetuses were at different stages of development. It was suggested that the development of the fetuses apparently continued in extrauterine pregnancy until the blood supply became inadquate for further growth.

• Clinical and Experimental Reproductive Medicine
• /
• 제15권2호
• /
• pp.129-133
• /
• 1988

Combined (intra and extrauterine) pregnancy refers to impregnations of two different ova at intrauterine and extrauterine sites simultaneously or within a short time interval each other. It is a rare clinical entity and freqently missed in early diagnosis in most instances. Its incidence rate is about 1 in 30,000 pregnancies and the incidence was rised in cases of using ovulation induced agents. The diagnostic rate is less than 10% at early process of the disease. We experienced a case of intrauterine and left tubal pregnancy as combined pregnaney in ovulation cycle which had been induced by clomiphene citrate and now present it with brief review of related leteratures.

• Clinical and Experimental Reproductive Medicine
• /
• 제21권3호
• /
• pp.335-339
• /
• 1994

Combined intrauterine and extrauterine pregnancy is rare, occuring 1 in 30,000 pregnancies. The early diagnosis of combined pregnancy is very difficult, and so there is a higher maternal morbidity and fetal loss. Recently the incidence of combined pregnancy is increased. We experienced a case of combined intrauterine and right tubal pregnancy, and this case was presented with a brief review of the literatures.

• Clinical and Experimental Reproductive Medicine
• /
• 제32권4호
• /
• pp.353-359
• /
• 2005

Heterotopic pregnancy is named when an extrauterine (ectopic) pregnancy coexists with an intrauterine pregnancy simultaneously by many causes such as PID (pelvic inflammatory disease), endometriosis, IUD (intrauterine device), previous pelvic surgery and others. This is very rare in general population, with a range of occurrence estimated between 1:7963 and 1:30000. But recently the incidence has increased as the uses of ARTs (assisted reproductive technologies) including ovulation induction, IVF-ET (in-vitro fertilization and embryo transfer) and GIFT (gamete intrafallopian transfer) increase. Because this has high maternal morbidity, mortality and fetal loss, early diagnosis and proper management is very important. We report a case of heterotopic pregnancy following IVF-ET with a brief review.

• Journal of Yeungnam Medical Science
• /
• 제10권1호
• /
• pp.245-252
• /
• 1993

저자들은 본 병원 산부인과에 입원하여 수술 후 조직학적으로 진단된 난소 임신 3례를 경험하였기에 이에 문헌고찰과 함께 보고하는 바이다.

• Clinical and Experimental Reproductive Medicine
• /
• 제38권2호
• /
• pp.109-114
• /
• 2011

Peritoneal pregnancy is an implantation in the peritoneal cavity exclusive of tubal, ovarian, or intra-ligamentary implantations. This is a rare obstetric complication with high maternal mortality and even higher perinatal mortality, and secondary type was most common. Risk factors for peritoneal pregnancy are previous history of extrauterine pregnancy or tubal surgery pelvic post-inflammatory status or presence of an intrauterine device. As it is a life-threatening condition, expectant management carries a risk of sudden life-threatening intra-abdominal bleeding and a generally poor fetal prognosis. So, when it is recognized, immediate termination of pregnancy is usually recommended. Early diagnosis of peritoneal pregnancy is difficult, but is important by their life threatening progress course to patients. Recently, we experienced primary peritoneal pregnancy which meets both the original and modified criteria. In this paper, we reported the case of early diagnosed and successfully treated peritoneal pregnancy despite of their diagnosis was incidentally.

• Clinical and Experimental Reproductive Medicine
• /
• 제33권1호
• /
• pp.69-69
• /
• 2006

병합임신은 두 개의 수정란이 자궁강 내와 자궁강 외에 동시에 착상되어 임신되는 것을 말한다. 그 예가 드물어 자연발생빈도는 약 30,000건의 임신 중 1명으로 나타나지만, 최근에는 불임환자의 체외 수정을 위한 배란 유도제의 사용이나 기타 생식 보조술의 발달, 골반내 염증, 난관수술로 인해 증가하고 있다. 병합임신은 조기 진단이 어려워 이에 따른 모성 사망률, 이환율이 높아지므로, 진단에 있어서 신중함이 중요하다. 저자들은 경찰병원에서 자연 생리주기에서 7주간의 무월경과 심한 하복부 통증을 주소로 내원한 29세 여환에서 발견된 좌측 난관임신과 자궁강 내 임신이 공존하는 병합임신을 간단한 문헌 고찰과 함께 보고하는 바이다.

• Nuclear Medicine and Molecular Imaging
• /
• 제41권3호
• /
• pp.258-259
• /
• 2007

Benign metastasizing leiomyoma(BML) is a rare condition affecting women with a history of having undergone hysterectomy or myomectomy for a benign uterine fibroid, that is found to have metastasized to extrauterine sites, usually many years after hysterectomy. 1,2) Patient with BML almost always asymptomatic, although if the lesions are large enough, they can cause compressive symptoms. Among several hypothesis of pathogenesis, most plausible theory is that these tumors represent a true metastatic lesion but are very low-grade sarcoma. 3) Because the tumor is responsive to estrogen, menopause and pregnancy have slowed the growth of these lesion 4) and it seems reasonable to perform hysterectomy in patients with a uterine mass and, at the same time, perform oophorectomy for hormonal control. BML is an unusual cause of diffuse pulmonary nodules which should be considered in females with unexplained nodules and a history of surgery for uterine leiomyoma.

• Clinical and Experimental Reproductive Medicine
• /
• 제27권4호
• /
• pp.353-357
• /
• 2000

Objective: Extrauterine formation of decidua of stromal cells has been well described, particularly in the cervix and ovary. The apparent hormonal mechanisn of this phenomenon suggestes a relationship to endometriosis. Whether formation of ectopic decidua represents a marked progestational response of endometriosis or an independent peritoneal-stromal reaction to pregnancy is unclear. This study was designed to determine the prevalence of deciduosis in the patients whose fertility were proven. Design: Prospective study of patients who had undergone cesarean delivery without history of endometriosis. Materials and Methods: The study was performed in 179 full tenn pregnant women. During the cesarean section, the pelvic organs were thoroughly investigated and the biopsies were collected at the lesions suspicious endometriosis. And then microscopic examination of removed tissues were done. Results: Of the 179 patients who underwent cesarean delivery, 48 women (26.8%) had the lesions suspicious endometriosis such as adhesion, pigmented spots. The ovary was the most frequently ocurred site (79.2%). Microscopically, decidual cells were observed in 34 cases (70.8%) of 48 biopsed patients. Conclusion: Endometriosis has been known to be associated with subfertility. Our observations found the prevalence of deciduosis was 19.0% (34/179) in tenn pregnant women whose fertilites were proven. We suggests that the deciduosis maya manifestation of endometriosis during pregnancy. However, further follow up study should be done to confirm this clinicopathologic process.

• Clinical and Experimental Reproductive Medicine
• /
• 제47권4호
• /
• pp.237-244
• /
• 2020

Endometrial cancer (EC) in young women tends to be early-stage and low-grade; therefore, such cases have good prognoses. Fertility-sparing treatment with progestin is a potential alternative to definitive treatment (i.e., total hysterectomy, bilateral salpingo-oophorectomy, pelvic washing, and/or lymphadenectomy) for selected patients. However, no evidence-based consensus or guidelines yet exist, and this topic is subject to much debate. Generally, the ideal candidates for fertility-sparing treatment have been suggested to be young women with grade 1 endometrioid adenocarcinoma confined to the endometrium. Magnetic resonance imaging should be performed to rule out myometrial invasion and extrauterine disease before initiating fertility-sparing treatment. Although various fertility-sparing treatment methods exist, including the levonorgestrel-intrauterine system, metformin, gonadotropin-releasing hormone agonists, photodynamic therapy, and hysteroscopic resection, the most common method is high-dose oral progestin (medroxyprogesterone acetate at 500-600 mg daily or megestrol acetate at 160 mg daily). During treatment, re-evaluation of the endometrium with dilation and curettage at 3 months is recommended. Although no consensus exists regarding the ideal duration of maintenance treatment after achieving regression, it is reasonable to consider maintaining the progestin therapy until pregnancy with individualization. According to the literature, the ovarian stimulation drugs used for fertility treatments appear safe. Hysterectomy should be performed after childbearing, and hysterectomy without oophorectomy can also be considered for young women. The available evidence suggests that fertility-sparing treatment is effective and does not appear to worsen the prognosis. If an eligible patient strongly desires fertility despite the risk of recurrence, the clinician should consider fertility-sparing treatment with close follow-up.